Log In
Print
BCIQ
Print
Print this Print this
 

Seebri Breezhaler, glycopyrronium bromide (NVA237) (formerly AD 237)

Also known as: Enurev Breezhaler, Tovanor Breezhaler

  Manage Alerts
Collapse Summary General Information
Company Sosei Group Corp.
DescriptionInhaled long-acting muscarinic receptor antagonist (LAMA)
Molecular Target Muscarinic receptor
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation

Partner

Novartis AG; Pfizer Inc.; Vectura Group plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today